SG Americas Securities’s Protalix BioTherapeutics PLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-21,467
| Closed | -$27K | – | 2746 |
|
|
2024
Q1 | $27K | Sell |
21,467
-13,139
| -38% | -$16.5K | ﹤0.01% | 2490 |
|
|
2023
Q4 | $62K | Buy |
34,606
+4,598
| +15% | +$8.24K | ﹤0.01% | 2622 |
|
|
2023
Q3 | $50K | Buy |
+30,008
| New | +$50K | ﹤0.01% | 2643 |
|
|
2020
Q2 | – | Sell |
-22,500
| Closed | -$53K | – | 3223 |
|
|
2020
Q1 | $53K | Hold |
22,500
| – | – | ﹤0.01% | 2680 |
|
|
2019
Q4 | $74K | Hold |
22,500
| – | – | ﹤0.01% | 2578 |
|
|
2019
Q3 | $46K | Hold |
22,500
| – | – | ﹤0.01% | 2392 |
|
|
2019
Q2 | $106K | Sell |
22,500
-16
| -0.1% | -$75 | ﹤0.01% | 2387 |
|
|
2019
Q1 | $99K | Buy |
22,516
+16
| +0.1% | +$70 | ﹤0.01% | 2689 |
|
|
2018
Q4 | $70K | Hold |
22,500
| – | – | ﹤0.01% | 2356 |
|
|
2018
Q3 | $164K | Hold |
22,500
| – | – | ﹤0.01% | 2315 |
|
|
2018
Q2 | $97K | Hold |
22,500
| – | – | ﹤0.01% | 2689 |
|
|
2018
Q1 | $121K | Buy |
+22,500
| New | +$121K | ﹤0.01% | 2384 |
|